Drug interactions with the taxanes: clinical implications
- 31 August 2001
- journal article
- review article
- Published by Elsevier in Cancer Treatment Reviews
- Vol. 27 (4) , 221-233
- https://doi.org/10.1053/ctrv.2001.0228
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- Pharmacokinetics of Ifosfamide Are Changed by Combination With DocetaxelAmerican Journal of Clinical Oncology, 2000
- Phase II Trial of the Combination of Paclitaxel and 5-Fluorouracil in the Treatment of Advanced Gastric CancerAmerican Journal of Clinical Oncology, 1999
- Inhibitory effects of combinations of HER-2/neu antibody and chemotherapeutic agents used for treatment of human breast cancersOncogene, 1999
- Sequence-dependent cytotoxicity of etoposide and paclitaxel in human breast and lung cancer cell linesCancer Chemotherapy and Pharmacology, 1998
- A phase I/II trial of paclitaxel for non-Hodgkinʼs lymphoma followed by paclitaxel plus quinine in drug-resistant diseaseAnti-Cancer Drugs, 1998
- The TaxoidsDrugs, 1998
- Predicting Drug Interactions In Vivo from Experiments In VitroAmerican Journal of Clinical Oncology, 1997
- Metabolism of taxol by human and rat liver in vitro: A screen for drug interactions and interspecies differencesCancer Chemotherapy and Pharmacology, 1995
- Taxol in combination with doxorubicin or etoposide possible antagonism in vitroCancer, 1993
- Phase II Trial of Taxol, an Active Drug in the Treatment of Metastatic Breast CancerJNCI Journal of the National Cancer Institute, 1991